Literature DB >> 23630658

Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review.

Min-Jie Yang1, Su Li, Yong-Guang Liu, Na Jiao, Jing-Shan Gong.   

Abstract

Pancreatic adenocarcinoma is the most common malignancy of the pancreas with high death rate. Preoperative imaging is crucial for the assessment of the disease and the planning of treatment. In this review, we discussed the common and unusual findings of pancreatic carcinoma. The common CT and MR findings include hypovascular mass, dilataion of upstream biliary and pancreatic ducts, invasion to adjacent structures and metastasis. The uncommon CT and MR findings include: a cystic mass, a mass without dilataion of upstream ducts, multiple masses or a lesion diffusively infiltrating most parts of the pancreas without distorting its configuration.

Entities:  

Keywords:  CT; MRI; Magnetic resonance cholangiopancreatography (MRCP); pancreatic adenocarcinoma

Year:  2013        PMID: 23630658      PMCID: PMC3636472          DOI: 10.3978/j.issn.2223-4292.2013.04.02

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  9 in total

Review 1.  MR imaging of pancreatic masses.

Authors:  D R Martin; R C Semelka
Journal:  Magn Reson Imaging Clin N Am       Date:  2000-11       Impact factor: 2.266

2.  Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform.

Authors:  Markus Kosmahl; Ursula Pauser; Martin Anlauf; Günter Klöppel
Journal:  Mod Pathol       Date:  2005-09       Impact factor: 7.842

Review 3.  Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma.

Authors:  Fergus V Coakley; Katryana Hanley-Knutson; John Mongan; Ramon Barajas; Matthew Bucknor; Aliya Qayyum
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

4.  Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas.

Authors:  T Ichikawa; H Sou; T Araki; A S Arbab; T Yoshikawa; K Ishigame; H Haradome; J Hachiya
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

5.  Imaging features of pancreatic neoplasms.

Authors:  P R Ros; K J Mortelé
Journal:  JBR-BTR       Date:  2001

6.  Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume.

Authors:  D J Gouma; R C van Geenen; T M van Gulik; R J de Haan; L T de Wit; O R Busch; H Obertop
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

7.  Pancreatic neoplasms: MR imaging and pathologic correlation.

Authors:  P J Mergo; T K Helmberger; P C Buetow; R C Helmberger; P R Ros
Journal:  Radiographics       Date:  1997 Mar-Apr       Impact factor: 5.333

8.  Complications following pancreaticoduodenectomy. Current management.

Authors:  B W Miedema; M G Sarr; J A van Heerden; D M Nagorney; D C McIlrath; D Ilstrup
Journal:  Arch Surg       Date:  1992-08

Review 9.  Chronic pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features.

Authors:  Aheed J Siddiqi; Frank Miller
Journal:  Semin Ultrasound CT MR       Date:  2007-10       Impact factor: 1.875

  9 in total
  3 in total

1.  On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues.

Authors:  Yì-Xiáng J Wáng; Jing-Shan Gong; Romaric Loffroy
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

2.  Imaging Characteristics and Prevalence of Pancreatic Carcinoma in Kosovo During 2011-2015 - Diagnostic Method as Choice.

Authors:  Kreshnike Dedushi; Serbeze Kabashi; Sefedin Mucaj; Gazmed Hasbahta; Naser Ramadani; Astrit Hoxhaj
Journal:  Acta Inform Med       Date:  2016-06-04

3.  Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT.

Authors:  Khoschy Schawkat; Wolfgang Kühn; Daniel Inderbitzin; Beat Gloor; Johannes T Heverhagen; Val Murray Runge; Andreas Christe
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.